 | • レポートコード：GIR-105X14419 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、網膜医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。網膜医薬品の種類別市場規模（黄斑変性症、糖尿病性眼疾患、網膜剥離、網膜芽細胞腫、黄斑パッカー、黄斑円孔、その他）、用途別市場規模（病院薬局、オンライン薬局、独立型薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・網膜医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Santen Pharmaceutical Co.，Ltd.、Regeneron Pharmaceuticals，Inc.、Takeda、Bayer AG、Novartis International AG、Valeant Pharmaceuticals International，Inc、Merck＆Co. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：黄斑変性症、糖尿病性眼疾患、網膜剥離、網膜芽細胞腫、黄斑パッカー、黄斑円孔、その他 ・用途別分析2016年-2026年：病院薬局、オンライン薬局、独立型薬局 ・網膜医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・網膜医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・網膜医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・網膜医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・網膜医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Retinal Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Retinal Pharmaceuticals size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Retinal Pharmaceuticals market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Retinal Pharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Macular Degeneration
Diabetic Eye Disease
Retinal Detachment
Retinoblastoma
Macular Pucker
Macular Hole
Others
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies
The key market players for global Retinal Pharmaceuticals market are listed below:
Santen Pharmaceutical Co.，Ltd.
Regeneron Pharmaceuticals，Inc.
Takeda
Bayer AG
Novartis International AG
Valeant Pharmaceuticals International，Inc
Merck＆Co.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Retinal Pharmaceuticals Introduction
1.2 Market Analysis
1.2.1 Overview: Global Retinal Pharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Macular Degeneration
1.2.3 Diabetic Eye Disease
1.2.4 Retinal Detachment
1.2.5 Retinoblastoma
1.2.6 Macular Pucker
1.2.7 Macular Hole
1.2.8 Others
1.3 Market Analysis
1.3.1 Overview: Global Retinal Pharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies
1.4 Global Retinal Pharmaceuticals Market Size & Forecast
1.4.1 Global Retinal Pharmaceuticals Sales in Value (2016-2026))
1.4.2 Global Retinal Pharmaceuticals Sales in Volume (2016-2026)
1.4.3 Global Retinal Pharmaceuticals Price by Type (2016-2026) & (USD/Kg)
1.5 Global Retinal Pharmaceuticals Production Capacity Analysis
1.5.1 Global Retinal Pharmaceuticals Total Production Capacity (2016-2026)
1.5.2 Global Retinal Pharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Pharmaceuticals Market Drivers
1.6.2 Retinal Pharmaceuticals Market Restraints
1.6.3 Retinal Pharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Santen Pharmaceutical Co.，Ltd.
2.1.1 Santen Pharmaceutical Co.，Ltd. Details
2.1.2 Santen Pharmaceutical Co.，Ltd. Major Business
2.1.3 Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Product and Services
2.1.4 Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Regeneron Pharmaceuticals，Inc.
2.2.1 Regeneron Pharmaceuticals，Inc. Details
2.2.2 Regeneron Pharmaceuticals，Inc. Major Business
2.2.3 Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Product and Services
2.2.4 Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Retinal Pharmaceuticals Product and Services
2.3.4 Takeda Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Retinal Pharmaceuticals Product and Services
2.4.4 Bayer AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis International AG
2.5.1 Novartis International AG Details
2.5.2 Novartis International AG Major Business
2.5.3 Novartis International AG Retinal Pharmaceuticals Product and Services
2.5.4 Novartis International AG Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Valeant Pharmaceuticals International，Inc
2.6.1 Valeant Pharmaceuticals International，Inc Details
2.6.2 Valeant Pharmaceuticals International，Inc Major Business
2.6.3 Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Product and Services
2.6.4 Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck＆Co.
2.7.1 Merck＆Co. Details
2.7.2 Merck＆Co. Major Business
2.7.3 Merck＆Co. Retinal Pharmaceuticals Product and Services
2.7.4 Merck＆Co. Retinal Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Retinal Pharmaceuticals Sales by Manufacturer
3.1 Global Retinal Pharmaceuticals Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Retinal Pharmaceuticals Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Retinal Pharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Retinal Pharmaceuticals Manufacturer Market Share
3.4.2 Top 6 Retinal Pharmaceuticals Manufacturer Market Share
3.5 Global Retinal Pharmaceuticals Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Retinal Pharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Retinal Pharmaceuticals Market Size by Region
4.1.1 Global Retinal Pharmaceuticals Sales in Volume by Region (2016-2026)
4.1.2 Global Retinal Pharmaceuticals Revenue by Region (2016-2026)
4.2 North America Retinal Pharmaceuticals Revenue (2016-2026)
4.3 Europe Retinal Pharmaceuticals Revenue (2016-2026)
4.4 Asia-Pacific Retinal Pharmaceuticals Revenue (2016-2026)
4.5 South America Retinal Pharmaceuticals Revenue (2016-2026)
4.6 Middle East and Africa Retinal Pharmaceuticals Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Retinal Pharmaceuticals Sales in Volume by Type (2016-2026)
5.2 Global Retinal Pharmaceuticals Revenue by Type (2016-2026)
5.3 Global Retinal Pharmaceuticals Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Retinal Pharmaceuticals Sales in Volume by Application (2016-2026)
6.2 Global Retinal Pharmaceuticals Revenue by Application (2016-2026)
6.3 Global Retinal Pharmaceuticals Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Retinal Pharmaceuticals Sales by Type (2016-2026)
7.2 North America Retinal Pharmaceuticals Sales by Application (2016-2026)
7.3 North America Retinal Pharmaceuticals Market Size by Country
7.3.1 North America Retinal Pharmaceuticals Sales in Volume by Country (2016-2026)
7.3.2 North America Retinal Pharmaceuticals Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Retinal Pharmaceuticals Sales by Type (2016-2026)
8.2 Europe Retinal Pharmaceuticals Sales by Application (2016-2026)
8.3 Europe Retinal Pharmaceuticals Market Size by Country
8.3.1 Europe Retinal Pharmaceuticals Sales in Volume by Country (2016-2026)
8.3.2 Europe Retinal Pharmaceuticals Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Retinal Pharmaceuticals Sales by Type (2016-2026)
9.2 Asia-Pacific Retinal Pharmaceuticals Sales by Application (2016-2026)
9.3 Asia-Pacific Retinal Pharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Retinal Pharmaceuticals Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Retinal Pharmaceuticals Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Retinal Pharmaceuticals Sales by Type (2016-2026)
10.2 South America Retinal Pharmaceuticals Sales by Application (2016-2026)
10.3 South America Retinal Pharmaceuticals Market Size by Country
10.3.1 South America Retinal Pharmaceuticals Sales in Volume by Country (2016-2026)
10.3.2 South America Retinal Pharmaceuticals Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Retinal Pharmaceuticals Sales by Type (2016-2026)
11.2 Middle East & Africa Retinal Pharmaceuticals Sales by Application (2016-2026)
11.3 Middle East & Africa Retinal Pharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Retinal Pharmaceuticals Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Retinal Pharmaceuticals Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Retinal Pharmaceuticals Typical Distributors
12.3 Retinal Pharmaceuticals Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Retinal Pharmaceuticals Revenue by Type, (USD Million), 2021-2026
Table 2. Global Retinal Pharmaceuticals Revenue by Application, (USD Million), 2021-2026
Table 3. Santen Pharmaceutical Co.，Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Santen Pharmaceutical Co.，Ltd. Major Business
Table 5. Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Product and Services
Table 6. Santen Pharmaceutical Co.，Ltd. Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Regeneron Pharmaceuticals，Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Regeneron Pharmaceuticals，Inc. Major Business
Table 9. Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Product and Services
Table 10. Regeneron Pharmaceuticals，Inc. Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Retinal Pharmaceuticals Product and Services
Table 14. Takeda Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 16. Bayer AG Major Business
Table 17. Bayer AG Retinal Pharmaceuticals Product and Services
Table 18. Bayer AG Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis International AG Major Business
Table 21. Novartis International AG Retinal Pharmaceuticals Product and Services
Table 22. Novartis International AG Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Valeant Pharmaceuticals International，Inc Basic Information, Manufacturing Base and Competitors
Table 24. Valeant Pharmaceuticals International，Inc Major Business
Table 25. Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Product and Services
Table 26. Valeant Pharmaceuticals International，Inc Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck＆Co. Basic Information, Manufacturing Base and Competitors
Table 28. Merck＆Co. Major Business
Table 29. Merck＆Co. Retinal Pharmaceuticals Product and Services
Table 30. Merck＆Co. Retinal Pharmaceuticals Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Retinal Pharmaceuticals Sales by Manufacturer (2019-2021e) & (MT)
Table 32. Global Retinal Pharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Retinal Pharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Retinal Pharmaceuticals Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and Retinal Pharmaceuticals Production Site of Key Manufacturer
Table 36. Global Retinal Pharmaceuticals Sales by Region (2016-2021e) & (MT)
Table 37. Global Retinal Pharmaceuticals Sales by Region (2021-2026) & (MT)
Table 38. Global Retinal Pharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Retinal Pharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 41. Global Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 42. Global Retinal Pharmaceuticals Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Retinal Pharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Retinal Pharmaceuticals Price by Type (2016-2021e) & (USD/Kg)
Table 45. Global Retinal Pharmaceuticals Price by Type (2021-2026) & (USD/Kg)
Table 46. Global Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 47. Global Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 48. Global Retinal Pharmaceuticals Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Retinal Pharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Retinal Pharmaceuticals Price by Application (2016-2021e) & (USD/Kg)
Table 51. Global Retinal Pharmaceuticals Price by Application (2021-2026) & (USD/Kg)
Table 52. North America Retinal Pharmaceuticals Sales by Country (2016-2021e) & (MT)
Table 53. North America Retinal Pharmaceuticals Sales by Country (2021-2026) & (MT)
Table 54. North America Retinal Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Retinal Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 57. North America Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 58. North America Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 59. North America Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 60. Europe Retinal Pharmaceuticals Sales by Country (2016-2021e) & (MT)
Table 61. Europe Retinal Pharmaceuticals Sales by Country (2021-2026) & (MT)
Table 62. Europe Retinal Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Retinal Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 65. Europe Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 66. Europe Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 67. Europe Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 68. Asia-Pacific Retinal Pharmaceuticals Sales by Region (2016-2021e) & (MT)
Table 69. Asia-Pacific Retinal Pharmaceuticals Sales by Region (2021-2026) & (MT)
Table 70. Asia-Pacific Retinal Pharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Retinal Pharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 73. Asia-Pacific Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 74. Asia-Pacific Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 75. Asia-Pacific Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 76. South America Retinal Pharmaceuticals Sales by Country (2016-2021e) & (MT)
Table 77. South America Retinal Pharmaceuticals Sales by Country (2021-2026) & (MT)
Table 78. South America Retinal Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Retinal Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 81. South America Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 82. South America Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 83. South America Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 84. Middle East & Africa Retinal Pharmaceuticals Sales by Country (2016-2021e) & (MT)
Table 85. Middle East & Africa Retinal Pharmaceuticals Sales by Country (2021-2026) & (MT)
Table 86. Middle East & Africa Retinal Pharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Retinal Pharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Retinal Pharmaceuticals Sales by Type (2016-2021e) & (MT)
Table 89. Middle East & Africa Retinal Pharmaceuticals Sales by Type (2021-2026) & (MT)
Table 90. Middle East & Africa Retinal Pharmaceuticals Sales by Application (2016-2021e) & (MT)
Table 91. Middle East & Africa Retinal Pharmaceuticals Sales by Application (2021-2026) & (MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Retinal Pharmaceuticals Typical Distributors
Table 95. Retinal Pharmaceuticals Typical Customers
List of Figures
Figure 1. Retinal Pharmaceuticals Picture
Figure 2. Global Retinal Pharmaceuticals Sales Market Share by Type in 2020
Figure 3. Macular Degeneration
Figure 4. Diabetic Eye Disease
Figure 5. Retinal Detachment
Figure 6. Retinoblastoma
Figure 7. Macular Pucker
Figure 8. Macular Hole
Figure 9. Others
Figure 10. Global Retinal Pharmaceuticals Sales Market Share by Application in 2020
Figure 11. Hospital Pharmacies
Figure 12. Online Pharmacies
Figure 13. Independent Pharmacies
Figure 14. Global Retinal Pharmaceuticals Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 15. Global Retinal Pharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Retinal Pharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Retinal Pharmaceuticals Sales (2016-2026) & (MT)
Figure 36. Global Retinal Pharmaceuticals Production Capacity (2016-2026) & (MT)
Figure 37. Global Retinal Pharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Retinal Pharmaceuticals Market Drivers
Figure 39. Retinal Pharmaceuticals Market Restraints
Figure 40. Retinal Pharmaceuticals Market Trends
Figure 41. Global Retinal Pharmaceuticals Sales Market Share by Manufacturer in 2020
Figure 42. Global Retinal Pharmaceuticals Revenue Market Share by Manufacturer in 2020
Figure 43. Retinal Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Retinal Pharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Retinal Pharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Retinal Pharmaceuticals Sales Market Share by Region (2016-2026)
Figure 47. Global Retinal Pharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 48. North America Retinal Pharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 49. Europe Retinal Pharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Retinal Pharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 51. South America Retinal Pharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Retinal Pharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 53. Global Retinal Pharmaceuticals Sales Market Share by Type (2016-2026)
Figure 54. Global Retinal Pharmaceuticals Revenue Market Share by Type (2016-2026)
Figure 55. Global Retinal Pharmaceuticals Price by Type (2016-2026) & (USD/Kg)
Figure 56. Global Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 57. Global Retinal Pharmaceuticals Revenue Market Share by Application (2016-2026)
Figure 58. Global Retinal Pharmaceuticals Price by Application (2016-2026) & (USD/Kg)
Figure 59. North America Retinal Pharmaceuticals Sales Market Share by Country (2016-2026)
Figure 60. North America Retinal Pharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 61. North America Retinal Pharmaceuticals Sales Market Share by Type (2016-2026)
Figure 62. North America Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 63. Europe Retinal Pharmaceuticals Sales Market Share by Country (2016-2026)
Figure 64. Europe Retinal Pharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 65. Europe Retinal Pharmaceuticals Sales Market Share by Type (2016-2026)
Figure 66. Europe Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Retinal Pharmaceuticals Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Retinal Pharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Retinal Pharmaceuticals Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 71. South America Retinal Pharmaceuticals Sales Market Share by Country (2016-2026)
Figure 72. South America Retinal Pharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 73. South America Retinal Pharmaceuticals Sales Market Share by Type (2016-2026)
Figure 74. South America Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Retinal Pharmaceuticals Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Retinal Pharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Retinal Pharmaceuticals Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Retinal Pharmaceuticals Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
加齢黄斑変性症遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…- 世界の網膜血管OCT機器市場 2021：企業別、地域別、種類・用途別 The Retinal Vascular OCT Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の網膜硝子体用プレフィルドシリコーンオイルシリンジ市場 2021：企業別、地域別、種類・用途別 The Vitreo Retinal Prefilled Silicone Oil Syringe market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のハンドヘルド網膜スキャナー市場 2021：企業別、地域別、種類・用途別 The Handheld Retinal Scanners market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 硝子体手術システムの世界市場2018-2025 Vitrectomy is a surgery that includes removing vitreous gel from the middle of the eye. Vitrectomy surgery usually occurs when there is a retinal detachment or blood in the vitreous gel that do not clear itself.The global market for Vitrectomy Systems market is expected to be driven by the increasin…